11-112086910-G-A
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The NM_003002.4(SDHD):c.3G>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003002.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDHD | ENST00000375549.8 | c.3G>A | p.Met1? | start_lost | Exon 1 of 4 | 1 | NM_003002.4 | ENSP00000364699.3 | ||
ENSG00000255292 | ENST00000532699.1 | n.3G>A | non_coding_transcript_exon_variant | Exon 1 of 6 | 3 | ENSP00000456434.1 | ||||
TIMM8B | ENST00000504148.3 | c.-187C>T | upstream_gene_variant | 1 | NM_012459.4 | ENSP00000422122.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pheochromocytoma;C1847319:Carney-Stratakis syndrome;C1868633:Paragangliomas with sensorineural hearing loss;CN166604:Cowden syndrome 3 Pathogenic:1
This sequence change affects the initiator methionine of the SDHD mRNA. The next in-frame methionine is located at codon 91. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with head and neck paraganglioma (HNPGL) and pheochromocytoma (PCC) (PMID: 11391796, 15066320, 17576205, 19258401, 19351833, 19454582, 21945342, 22241717). ClinVar contains an entry for this variant (Variation ID: 579968). For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.M1? pathogenic mutation (also known as c.3G>A) is located in coding exon 1 of the SDHD gene and results from a G to A substitution at nucleotide position 3. This alters the methionine residue at the initiation codon. This mutation has been observed in multiple individuals with pheochromocytomas and/or paragangliomas (Cascón A et al. J. Clin. Endocrinol. Metab. 2009 May;94(5):1701-5; Ben Aim L et al. J. Med. Genet. 2019 Aug;56(8):513-520; Ambry Internal Data). In addition to the clinical data presented in the literature, since sequence variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at